Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema
Indian Journal of Ophthalmology · 2023
DOI: 10.4103/ijo.ijo_345_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Ophthalmology, 2023. Verfasst von Chewang U Bhutia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, GMC Amritsar, Punjab, India. Hauptthemen laut MEDLINE: Macular Edema, Diabetic Retinopathy, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
To determine the correlation between serum inflammatory and metabolic biomarkers of patients with diabetic retinopathy (DR) and diabetic macular edema (DME).
Methods
Serum samples were obtained from 100 diabetic patients. Patients were divided into three groups: group 1 (patients with no DR, n = 27), group 2 (DR with DME, n = 34), and group 3 (DR without DME, n = 39). Serum concentrations of C-reactive protein (CRP) and interleukin-6 (IL-6) were measured by quantitative turbidimetric immunoassay and sandwich chemiluminescence immunoassay, respectively. Metabolic parameters such as glycated hemoglobin (HbA1c), total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride (TG), serum creatinine, and blood urea were determined by automated analyzer om-360 after standardization.
Results
The levels of IL-6 and CRP differed significantly in patients with DR and without DR ( P < 0.001 and P = 0.045, respectively). We also found a positive correlation between IL-6 and CRP with the severity of DR. When DR patients with DME were compared to patients without DME, only IL-6 was observed to be significantly elevated ( P < 0.001). None of the metabolic markers correlated significantly with DR and DME.
Conclusion
Significantly raised levels of serum inflammatory biomarkers can be used to elucidate the significant role of inflammation in the pathogenesis of DR. Therefore, circulating biomarkers can serve as diagnostic and therapeutic predictors for monitoring the onset and progression of DR and DME.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, GMC Amritsar, Punjab, India.
- Department of Biochemistry, GMC Amritsar, Punjab, India.
Zitieren
APA
Bhutia, C. U., Kaur, P., Singh, K., & Kaur, S. (2023). Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_345_23
Vancouver
Bhutia CU, Kaur P, Singh K, Kaur S. Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema. Indian Journal of Ophthalmology. 2023. doi:10.4103/ijo.ijo_345_23
BibTeX
@article{Bhutia2023,
author = {Bhutia, Chewang U and Kaur, Prempal and Singh, Karamjit and Kaur, Sukhraj},
title = {Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema},
journal = {Indian Journal of Ophthalmology},
year = {2023},
doi = {10.4103/ijo.ijo_345_23}
}
EUVIMED